Table 3

Adverse events during 12 month study.

Adverse eventsn(%)
Upper Respiratory tract Infection20(3.33)
Headache10(16.66)
Urinary Tract Infection8(13.33)
Menstrual irregularity5(8.33)
Pneumonia3(5.0)
Dyspnea3(5.0)
Anxiety2(3.33)
Influenza1(1.66)
Dyspepsia1(1.66)
Restless Leg Syndrome1(1.66)
Depression1(1.66)